Annual Working Capital
$64.23 M
-$100.21 M-60.94%
December 31, 2024
Summary
- As of February 22, 2025, KPTI annual working capital is $64.23 million, with the most recent change of -$100.21 million (-60.94%) on December 31, 2024.
- During the last 3 years, KPTI annual working capital has fallen by -$137.66 million (-68.19%).
- KPTI annual working capital is now -77.68% below its all-time high of $287.71 million, reached on December 31, 2018.
Performance
KPTI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
N/A
December 31, 2024
Summary
- KPTI quarterly working capital is not available.
Performance
KPTI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KPTI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.9% | - |
| 3 y3 years | -68.2% | - |
| 5 y5 years | -72.3% | - |
KPTI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.4% | at low | ||
| 5 y | 5-year | -77.4% | at low | ||
| alltime | all time | -77.7% | +6680.7% |
Karyopharm Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $64.23 M(-60.9%) | - |
| Sep 2024 | - | $123.26 M(-18.3%) |
| Jun 2024 | - | $150.92 M(+13.5%) |
| Mar 2024 | - | $133.03 M(-19.1%) |
| Dec 2023 | $164.44 M(-42.1%) | $164.44 M(-18.2%) |
| Sep 2023 | - | $201.14 M(-13.5%) |
| Jun 2023 | - | $232.45 M(-9.5%) |
| Mar 2023 | - | $256.99 M(-9.6%) |
| Dec 2022 | $284.25 M(+40.8%) | $284.25 M(+76.6%) |
| Sep 2022 | - | $160.92 M(-10.6%) |
| Jun 2022 | - | $179.91 M(-14.4%) |
| Mar 2022 | - | $210.20 M(+4.1%) |
| Dec 2021 | $201.89 M(-6.7%) | $201.89 M(+16.9%) |
| Sep 2021 | - | $172.71 M(-19.8%) |
| Jun 2021 | - | $215.38 M(+11.3%) |
| Mar 2021 | - | $193.50 M(-10.6%) |
| Dec 2020 | $216.33 M(-6.8%) | $216.33 M(-7.1%) |
| Sep 2020 | - | $232.82 M(-12.9%) |
| Jun 2020 | - | $267.27 M(-16.8%) |
| Mar 2020 | - | $321.22 M(+38.3%) |
| Dec 2019 | $232.22 M(-19.3%) | $232.22 M(-3.9%) |
| Sep 2019 | - | $241.66 M(+26.8%) |
| Jun 2019 | - | $190.66 M(-16.2%) |
| Mar 2019 | - | $227.57 M(-20.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $287.71 M(+190.7%) | $287.71 M(+69.2%) |
| Sep 2018 | - | $170.00 M(-18.3%) |
| Jun 2018 | - | $208.01 M(+140.3%) |
| Mar 2018 | - | $86.58 M(-12.5%) |
| Dec 2017 | $98.96 M(-14.1%) | $98.96 M(-1.6%) |
| Sep 2017 | - | $100.53 M(-21.6%) |
| Jun 2017 | - | $128.20 M(+32.5%) |
| Mar 2017 | - | $96.75 M(-16.0%) |
| Dec 2016 | $115.16 M(-29.1%) | $115.16 M(-0.1%) |
| Sep 2016 | - | $115.30 M(+6.1%) |
| Jun 2016 | - | $108.68 M(-13.0%) |
| Mar 2016 | - | $124.92 M(-23.1%) |
| Dec 2015 | $162.47 M(-16.9%) | $162.47 M(-11.7%) |
| Sep 2015 | - | $183.90 M(-12.9%) |
| Jun 2015 | - | $211.15 M(-10.0%) |
| Mar 2015 | - | $234.62 M(+20.0%) |
| Dec 2014 | $195.45 M(+26.4%) | $195.45 M(-13.2%) |
| Sep 2014 | - | $225.11 M(+73.6%) |
| Jun 2014 | - | $129.64 M(-9.1%) |
| Mar 2014 | - | $142.55 M(-7.8%) |
| Dec 2013 | $154.66 M(<-9900.0%) | $154.66 M(+211.9%) |
| Sep 2013 | - | $49.59 M(-16.9%) |
| Jun 2013 | - | $59.65 M(-6211.5%) |
| Dec 2012 | -$976.00 K(-120.6%) | -$976.00 K |
| Dec 2011 | $4.75 M | - |
FAQ
- What is Karyopharm Therapeutics annual working capital?
- What is the all time high annual working capital for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual working capital year-on-year change?
- What is the all time high quarterly working capital for Karyopharm Therapeutics?
What is Karyopharm Therapeutics annual working capital?
The current annual working capital of KPTI is $64.23 M
What is the all time high annual working capital for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual working capital is $287.71 M
What is Karyopharm Therapeutics annual working capital year-on-year change?
Over the past year, KPTI annual working capital has changed by -$100.21 M (-60.94%)
What is the all time high quarterly working capital for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly working capital is $321.22 M